This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Gilead Sciences, Inc., Janssen Sciences Ireland Uc. Active years: 2020.
Company Filing History:
1 out of 946 
1 out of 111 
Years Active: 2020
Title: Katia Boven: Innovator in HIV Treatment
Introduction
Katia Boven is a notable inventor based in Titusville, NJ (US). She has made significant contributions to the field of medicine, particularly in the treatment of HIV. Her innovative work has led to the development of a patent that addresses critical health challenges.
Latest Patents
Katia Boven holds a patent for "Compositions and methods of treating HIV." This patent focuses on methods for treating subjects infected with HIV using a once-daily regimen. The treatment involves single unit dosage forms that include darunavir, cobicistat, emtricitabine, and a tenofovir prodrug or its salt. This advancement represents a significant step forward in HIV treatment options.
Career Highlights
Throughout her career, Katia has worked with prominent companies in the pharmaceutical industry. She has been associated with Janssen Sciences Ireland UC and Gilead Sciences, Inc. These experiences have allowed her to contribute to groundbreaking research and development in HIV therapies.
Collaborations
Katia has collaborated with esteemed colleagues, including Goedele De Smedt and Regina Driesen. These partnerships have fostered an environment of innovation and have been instrumental in her research endeavors.
Conclusion
Katia Boven's work in HIV treatment exemplifies her dedication to improving healthcare outcomes. Her patent and collaborations highlight her significant impact in the field of medicine.